Pharmacovigilance of herbal products in India
- PMID: 21897669
- PMCID: PMC3159283
- DOI: 10.4103/0975-1483.83780
Pharmacovigilance of herbal products in India
Abstract
Herbal formulations being widely accepted therapeutic agents as antidiabetics, antiarthritics, hepatoprotectives, cough remedies, memory enhancers, and adaptogens. The commonest myth regarding herbal medicines is that these medicines are completely safe, and can therefore be safely consumed by the patient on his/her own, without a physician's prescription. This belief has led to large-scale self-medication by people all over the world, often leading to disappointing end-results, side-effects, or unwanted after-effects. There is an increasing awareness at several levels of the need to develop pharmacovigilance practices for herbal medicines. The current model of pharmacovigilance and its associated tools have been developed in relation to synthetic drugs, and applying these methods to monitoring the safety of herbal medicines presents unique challenges in addition to those described for conventional medicines. Several problems relate to the ways in which herbal medicines are named, perceived, sourced, and utilized. This may be because of differences in the use of nonorthodox drugs (e.g., herbal remedies) which may pose special toxicological problems, when used alone or in combination with other drugs. The purpose of pharmacovigilance is to detect, assess, and understand, and to prevent the adverse effects or any other possible drug-related problems, related to herbal, traditional, and complementary medicines.
Keywords: Adverse reaction; herbal medicines; pharmacovigilance.
Conflict of interest statement
Similar articles
-
Pharmacovigilance of herbal medicines : a UK perspective.Drug Saf. 2003;26(12):829-51. doi: 10.2165/00002018-200326120-00001. Drug Saf. 2003. PMID: 12959628 Review.
-
Pharmacovigilance in Herbal Drugs: A Challenge.Curr Drug Saf. 2023;18(2):138-142. doi: 10.2174/1574886317666220428125943. Curr Drug Saf. 2023. PMID: 36883268
-
A study on pharmacovigilance of herbal medicines in Lagos West Senatorial District, Nigeria.Int J Risk Saf Med. 2013;25(4):205-17. doi: 10.3233/JRS-130604. Int J Risk Saf Med. 2013. PMID: 24305559
-
Pharmacovigilance of herbal medicines.Int J Risk Saf Med. 2015;27(2):55-65. doi: 10.3233/JRS-150643. Int J Risk Saf Med. 2015. PMID: 26410008
-
Advancing herbal medicine safety: the need for a global pharmacovigilance approach.Naunyn Schmiedebergs Arch Pharmacol. 2025 May 8. doi: 10.1007/s00210-025-04066-2. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40338319 Review.
Cited by
-
Adverse drug reaction and concepts of drug safety in Ayurveda: An overview.J Young Pharm. 2013 Dec;5(4):116-20. doi: 10.1016/j.jyp.2013.10.001. Epub 2013 Oct 23. J Young Pharm. 2013. PMID: 24563588 Free PMC article. Review.
-
A rapid HPTLC method to estimate piperine in Ayurvedic formulations.J Ayurveda Integr Med. 2019 Oct-Dec;10(4):248-254. doi: 10.1016/j.jaim.2017.07.006. Epub 2018 Oct 11. J Ayurveda Integr Med. 2019. PMID: 30318249 Free PMC article.
-
Phytochemicals as modulators of M1-M2 macrophages in inflammation.Oncotarget. 2018 Apr 3;9(25):17937-17950. doi: 10.18632/oncotarget.24788. eCollection 2018 Apr 3. Oncotarget. 2018. PMID: 29707159 Free PMC article. Review.
References
-
- Geneva: World Health Organization; 2004. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems; p. 19.
-
- Williamson E. Drug interactions between herbal and prescription medicines. Drug Saf. 2003;26:1075–92. - PubMed
-
- Jordan SA, Cunningham DG, Marles RJ. Assessment of herbal medicinal products: Challenges, and opportunities to increase the knowledge base for safety sassessment. Toxicol Appl Pharmacol. 2010;243:198–216. - PubMed
-
- Health Canada, 2009a. Release of the guidance document for industry - reporting adverse reactions to marketed health products. 2009. Jul 09, [last accessed on 2009 Sep 28]. Available from: http://www.hc-sc.gc.ca/dhp-mps/pubs/medeff/_guide/2009-guidance-directri... .
-
- Farah MH, Edwards R, Lindquist M, Leon C, Shaw D. International monitoring of adverse health effects associated with herbal medicines. Pharmacoepidemiol Drug Saf. 2000;9:105–12. - PubMed